A shift is evident in the healthcare and biotech industry that is steadily moving toward a digital future. A future where ...

Amgen AMGN and Bristol Myers Squibb BMY are among the largest global biotechnology companies with broad and diverse ...

FBT ETF launched 19 years ago and has delivered exceptional returns compared to the broader Health Care sector. Read why FBT ...

The Bay Area's biotech industry faces an uncertain future after 50 years. But industry leaders see a history of resilience ...

Biotech, one of the Bay Area's most important industries, sprang up in five short decades. Here are the key moments to know ...

appeared on CNBC to discuss how tariffs and policy risks are pressuring the biotech industry, while simultaneously iterating that low valuations in the sector may present buying opportunities once ...

Shortly afterward, up-and-coming venture capitalist Robert Swanson pitched Boyer on co-founding the first biotech company, which they named Genentech, Inc. Boyer and Cohen had produced a new era of ...

Layoffs, slower hiring and federal cuts threaten biotech’s workforce just when the industry seeks to expand into empty real estate.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

Performance data quoted represents past performance, which does not guarantee future results. Current performance may be lower or higher than the figures shown. Principal value and investment ...

With one of the most densely concentrated life sciences hubs in Europe, the Netherlands sets its sights on becoming a global ...

Amgen boasts one of the largest portfolios in the biotech industry with a strong presence in the oncology, cardiovascular disease, inflammation, bone health and rare disease markets. Bristol Myers ...